Author
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
4 papers
Recent·Most cited
T. M. Grubb, J. Khatun, S. Matar…·A. A. Chakraborty
This study identifies SLC1A1/EAAT3 as an oncogenic transporter in ccRCC driven by H3K27ac, showing its role in sustaining metabolic programs and its potential as a therapeutic target.
T. M. Grubb, S. Maganti, J. M. Krill-Burger…·A. Chakraborty
The paper identifies a mesenchymal tumor cell state that increases dependency on BCL-XL in kidney cancer, showing anti-tumor efficacy of a BCL-XL inhibitor.
D. D. Shi, M. R. Savani, M. M. Levitt…·McBray
This study identifies de novo pyrimidine synthesis as a therapeutic target in IDH mutant gliomas, showing that DHODH inhibitors are effective in preclinical models.
P. L. Sulkowski, H. E. Nicholson, M. Z. Li…·W. G. Kaelin
The authors withdrew their manuscript due to irreproducible and non-robust results regarding histone H3 horizontal transfer.